MA47122A - Vaccin à adn multi-épitope contre la cowdriose - Google Patents

Vaccin à adn multi-épitope contre la cowdriose

Info

Publication number
MA47122A
MA47122A MA047122A MA47122A MA47122A MA 47122 A MA47122 A MA 47122A MA 047122 A MA047122 A MA 047122A MA 47122 A MA47122 A MA 47122A MA 47122 A MA47122 A MA 47122A
Authority
MA
Morocco
Prior art keywords
cowdriosis
dna vaccine
vaccine against
epitope dna
epitope
Prior art date
Application number
MA047122A
Other languages
English (en)
Inventor
Frederika Elizabeth Faber
Junita Liebenberg
Alri Pretorius
Helena Cornelia Steyn
Nontobeko Thema
Selaelo Ivy Tshilwane
Kleef Mirinda Van
Original Assignee
Agricultural Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Research Council filed Critical Agricultural Research Council
Publication of MA47122A publication Critical patent/MA47122A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MA047122A 2016-12-20 2017-12-20 Vaccin à adn multi-épitope contre la cowdriose MA47122A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1621732.5A GB201621732D0 (en) 2016-12-20 2016-12-20 A multi-epitope dna vaccine for heartwater

Publications (1)

Publication Number Publication Date
MA47122A true MA47122A (fr) 2019-10-30

Family

ID=58284286

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047122A MA47122A (fr) 2016-12-20 2017-12-20 Vaccin à adn multi-épitope contre la cowdriose

Country Status (6)

Country Link
US (1) US10682403B2 (fr)
EP (1) EP3559023B1 (fr)
GB (1) GB201621732D0 (fr)
MA (1) MA47122A (fr)
WO (1) WO2018116193A1 (fr)
ZA (1) ZA201904764B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019013259A (es) 2017-05-08 2020-01-13 Gritstone Oncology Inc Vectores de neoantigeno de alfavirus.
TW202000907A (zh) * 2018-05-23 2020-01-01 美商葛利史東腫瘤科技公司 共有抗原
JP7457733B2 (ja) 2019-05-30 2024-03-28 グリットストーン バイオ インコーポレイテッド 改変アデノウイルス
EP4192496A4 (fr) 2020-08-06 2025-01-01 Gritstone bio, Inc. Cassettes de vaccin à plusieurs épitopes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1

Also Published As

Publication number Publication date
WO2018116193A1 (fr) 2018-06-28
ZA201904764B (en) 2022-09-28
US20190307871A1 (en) 2019-10-10
EP3559023B1 (fr) 2021-06-09
GB201621732D0 (en) 2017-02-01
US10682403B2 (en) 2020-06-16
EP3559023A1 (fr) 2019-10-30

Similar Documents

Publication Publication Date Title
IL288461A (en) Targeted nucleic acid conjugate compositions
MA43762A (fr) Vaccin contre le rsv
MA47401A (fr) Vaccins anticancéreux à arn
DK3393510T5 (da) Zikavirusvaccine
MA46584A (fr) Vaccin contre le cytomégalovirus humain
MA46766A (fr) Vaccin antigrippal
MA47016A (fr) Vaccins contre les virus respiratoires
MA46316A (fr) Vaccin contre le cytomégalovirus humain
DK4023249T3 (da) Nukleinsyrevacciner
EP3324979A4 (fr) Vaccins contre une maladie infectieuse
EP3364950A4 (fr) Vaccins contre des maladies tropicales
EP3364949A4 (fr) Vaccins anticancéreux
MA46317A (fr) Vaccin contre le virus respiratoire syncytial
DK3262066T4 (da) Genterapi
PL3534945T3 (pl) Szczepionka przeciwko parwowirusowi świń
DK3313436T3 (da) Multivalent pneumokok-konjugatvaccine
EP3273989C0 (fr) Vaccin streptococcique
EP3385286A4 (fr) Antigène vaccinal à immunogénicité accrue
EP3560512A4 (fr) Composition de vaccin contre le zona
ZA201704596B (en) Foot-and-mouth disease vaccine
FR24C1042I1 (fr) Vaccin à large spectre contre un réovirus aviaire
IL266237A (en) Tolerogenic DNA composition
DK3310379T3 (da) Vegfr-2-targeterende dna-vaccine til kombinationsterapi
MA47122A (fr) Vaccin à adn multi-épitope contre la cowdriose
EP3500280A4 (fr) Vaccins contre des virus